The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results